Chronic Myeloid Leukemia: Know Your Options
Topics Covered
We invite you to learn more about:
- Treatment advances for chronic myeloid leukemia (CML)
- Monitoring CML
- Treatment-free remission
- Side-effects management
- Discussing quality-of-life issues with my healthcare team
Speaker
Kendra Sweet, MD, MS
Assistant Member, Department of
Malignant Hematology
Moffitt Cancer Center
Tampa, FL
Audio Replay
Program Materials
Program Support
Support for this program provided by Bristol-Myers Squibb, Novartis, and Takeda Oncology.
Insight into Chronic Myeloid Leukemia (CML)
Topics Covered
We invite you to learn more about:
- The importance of monitoring your CML
- Treatment options for CML
- Treatment-free remission
- Side effects and quality-of-life issues for patients
Speaker
Stuart Goldberg, MD
Chair, Division of Outcomes Research
John Theurer Cancer Center
Associate Professor, Medicine
Hackensack Meridian School of Medicine
Hackensack, NJ
Audio Replay
Program Materials
Program Support
Support for this program is provided by Bristol Myers Squibb, Novartis Pharmaceuticals Corporation, Pfizer Inc. and Takeda Oncology.
Advances in Chronic Myeloid Leukemia
Topics Covered
We invite you to learn more about:
- Treatment advances for chronic myeloid leukemia (CML)
- The concept of treatment-free remission
- Supportive care and side-effects management
- How communicating with your healthcare team can improve your quality-of-life
Speaker
Alison W. Loren, MD, MSCE
Associate Professor of Medicine
Vice Chair, Faculty Development
Department of Medicine
Perelman School of Medicine
University of Pennsylvania
Philadelphia, PA
Audio Replay
Program Materials
Program Support
Support for this program provided by Bristol-Myers Squibb, Novartis, and Takeda Oncology.
Highlights in Therapy: Chronic Myeloid Leukemia (CML)
Topics Covered
We invite you to learn more about:
- CML treatment and monitoring
- New therapies on the horizon for CML
- Side-effects management
- Treatment free remission
- Quality of life issues
Speaker
Gabriela Hobbs, MD
Clinical Director, Leukemia Service
Massachusetts General Hospital
Assistant Professor
Harvard Medical School
Boston, MA
Program Materials
Program Support
Support for this program is provided by The Leukemia & Lymphoma Society.
The Future of CML Treatment: What’s Next?
Topics Covered
We invite you to learn more about:
- Novel treatments for chronic myeloid leukemia (CML)
- The importance of monitoring your CML
- Effectively managing side effects
- Communication with your treatment team
Program Materials
Speaker
Vivian G. Oehler, MD
Associate Professor, Division of
Translational Science and Therapeutics
Fred Hutchinson Cancer Center Division of Hematology/Oncology
University of Washington
Seattle, WA
Program Support
Support for this program provided by Novartis Pharmaceuticals Corporation.